Target intelligence / Profile preview

Dopamine D1 receptor in Angiotensin II type 1 receptor–Dopamine D1 receptor heterodimer (AT1R–D1R heterodimer)

Target
AT1R–D1R heterodimer
Molecular classification
G protein-coupled receptor, GPCR heteromer, Receptor
01

Overview

The Dopamine D1 receptor (D1R) in the Angiotensin II type 1 receptor (AT1R)–D1R heterodimer is a functional complex primarily located in the renal proximal tubule (Zeng et al., 2003, Hypertension). This heterodimer mediates the counter-regulatory relationship between the pro-natriuretic dopaminergic system and the anti-natriuretic renin-angiotensin system (Jose et al., 2008, J Am Soc Nephrol). Within the complex, the receptors exhibit reciprocal allosteric inhibition; for example, AT1R activation can uncouple D1R from its G-protein, thereby reducing sodium excretion (Armando et al., 2015, Curr Opin Nephrol Hypertens). Conversely, D1R activation can inhibit AT1R-mediated phospholipase C activity and calcium mobilization. This interaction is crucial for maintaining blood pressure, and its disruption is linked to the development of essential hypertension (Zeng et al., 2003). Pharmacological intervention often targets this complex using AT1R antagonists or D1R agonists to restore sodium balance and lower blood pressure.

Other names
AT1R-D1R complexAngiotensin II type 1 receptor-Dopamine D1 receptor heteromerD1R-AT1R heterodimerDopamine D1 receptor-Angiotensin II type 1 receptor complex
02

Mechanism of action

Reciprocal allosteric modulation where activation of one receptor within the heterodimer inhibits the signaling and function of the partner receptor to regulate sodium transport.

03

Biological functions

Signal transductionSodium homeostasisBlood pressure regulationRenal hemodynamicsNatriuresis
04

Disease associations

HypertensionCardiovascular diseaseRenal failureSalt-sensitive hypertension
05

Safety considerations

HypotensionElectrolyte imbalanceRenal perfusion changesPotential for altered dopaminergic signaling in the central nervous system
06

Interacting drugs

Candesartan

5 more in the full profile.

07

Biomarkers

Urinary sodium excretionRenal AT1R/D1R protein expression ratioPlasma renin activity

Beyond the preview

Go deeper on Dopamine D1 receptor in Angiotensin II type 1 receptor–Dopamine D1 receptor heterodimer (AT1R–D1R heterodimer).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dopamine D1 receptor in Angiotensin II type 1 receptor–Dopamine D1 receptor heterodimer (AT1R–D1R heterodimer).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call